+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

Gene Vector - Global Strategic Business Report - Product Thumbnail Image

Gene Vector - Global Strategic Business Report

  • Report
  • June 2026
  • 480 Pages
  • Global
From
Cell Freezing Media - Global Strategic Business Report - Product Thumbnail Image

Cell Freezing Media - Global Strategic Business Report

  • Report
  • June 2026
  • 279 Pages
  • Global
From
From
Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Cell Therapy - Global Strategic Business Report

  • Report
  • June 2026
  • 263 Pages
  • Global
From
Human Platelet Lysate - Global Strategic Business Report - Product Thumbnail Image

Human Platelet Lysate - Global Strategic Business Report

  • Report
  • June 2026
  • 215 Pages
  • Global
From
Cell Analysis - Global Strategic Business Report - Product Thumbnail Image

Cell Analysis - Global Strategic Business Report

  • Report
  • June 2026
  • 273 Pages
  • Global
From
Synthetic Genes - Global Strategic Business Report - Product Thumbnail Image

Synthetic Genes - Global Strategic Business Report

  • Report
  • June 2026
  • 181 Pages
  • Global
From
From
Cell Expansion - Global Strategic Business Report - Product Thumbnail Image

Cell Expansion - Global Strategic Business Report

  • Report
  • June 2026
  • 188 Pages
  • Global
From
From
From
From
Cell Dissociation - Global Strategic Business Report - Product Thumbnail Image

Cell Dissociation - Global Strategic Business Report

  • Report
  • June 2026
  • 193 Pages
  • Global
From
Osteosarcoma - Pipeline Insight, 2026 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
CTLA-4 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

CTLA-4 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 220 Pages
  • Global
From
From
From
From
From
Hepatic Tumor Pipeline Analysis Report 2025 - Product Thumbnail Image

Hepatic Tumor Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more